PDS Biotechnology Corporation

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: PDS Biotechnology Corporation
Former names: Edge Therapeutics, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Princeton
Headquarters state / province: New Jersey
Headquarters country: United States
Fiscal year end: December
Ticker symbol: PDSB
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001472091
EIN: 26-4231384

Board of directors

Follow this board

Arnold James Banaag · Director
Since 2026
Bruce Wendel · Director
Since 2026
Deborah Ramsdell · Director
Since 2026
Frank Bedu-Addo · Director · President/CEO
Since 2023
Gregory Gene Freitag · Director
Since 2023
Ilian Iliev · Director
Since 2023
John Andrew Dawson · Director
Since 2026
Kamil Ali-Jackson · Director
Since 2023
Otis W. Brawley · Director
Since 2023
Patrick Soon-Shiong · Director
Since 2026
Richard Sykes · Director
Since 2023
Stephen C. Glover · Director
Since 2023

Chief executives

Frank Bedu-Addo · President/CEO

Dates unknown

Director election results

Annual meeting of August 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Kamil Ali-Jackson

73.3%
Ilian Iliev

76.7%

Board connections

6 of this board's directors also sit on 8 other boards. 7 are in the same sector.

Shared director Other board Same sector

ImmunityBio Inc. Same sector
via Bruce Wendel and Patrick Soon-Shiong
Agilent Technologies Inc.
via Otis W. Brawley
Axogen Inc. Same sector
via Gregory Gene Freitag
GT Biopharma Inc. Same sector
via Bruce Wendel
Incyte Corp. Same sector
via Otis W. Brawley
Lyell Immunopharma Inc. Same sector
via Otis W. Brawley
Oncolytics Biotech Inc. Same sector
via Stephen C. Glover
Rigel Pharmaceuticals Inc. Same sector
via Kamil Ali-Jackson

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Feb 28, 2025	Gregory Gene Freitag Director	Open-market purchase	+15,060	$1.66	$25,000
Feb 28, 2025	Stephen C. Glover Director	Open-market purchase	+15,061	$1.66	$25,001

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about PDS Biotechnology Corporation

Who is the CEO of PDS Biotechnology Corporation?

Frank Bedu-Addo is PDS Biotechnology Corporation's President/CEO.

How many directors are on PDS Biotechnology Corporation's board?

PDS Biotechnology Corporation's board has 12 directors: Arnold James Banaag, Bruce Wendel, Deborah Ramsdell, Frank Bedu-Addo, Gregory Gene Freitag, Ilian Iliev, John Andrew Dawson, Kamil Ali-Jackson, Otis W. Brawley, Patrick Soon-Shiong and 2 others.

How is PDS Biotechnology Corporation connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="pds-biotechnology-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.